BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22049219)

  • 1. Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport.
    Ashenden M; Clarke A; Sharpe K; d'Onofrio G; Allbon G; Gore CJ
    J Clin Pathol; 2012 Jan; 65(1):8-13. PubMed ID: 22049219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of athlete passport parameters during extended storage.
    Ashenden M; Clarke A; Sharpe K; d'Onofrio G; Plowman J; Gore CJ
    Int J Lab Hematol; 2013 Apr; 35(2):183-92. PubMed ID: 23067319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of athlete blood passport parameters during air freight.
    Ashenden M; Sharpe K; Plowman J; Allbon G; Lobigs L; Baron A; Gore CJ
    Int J Lab Hematol; 2014 Oct; 36(5):505-13. PubMed ID: 24373122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of the Sysmex XT-2000i automated hematology analyzer.
    Langford K; Luchtman-Jones L; Miller R; Walck D
    Lab Hematol; 2003; 9(1):29-37. PubMed ID: 12661825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of transport and time on blood variables commonly measured for the athlete biological passport.
    Robinson N; Giraud S; Schumacher YO; Saugy M
    Drug Test Anal; 2016 Feb; 8(2):199-207. PubMed ID: 25924812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated and automatic mixing of whole blood: an evaluation of a novel blood gas analyzer.
    Grenache DG; Parker C
    Clin Chim Acta; 2007 Jan; 375(1-2):153-7. PubMed ID: 16905126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2011 lAAF World Championships in Daegu: blood tests for all athletes in the framework of the Athlete Biological Passport.
    Robinson N; Dollé G; Garnier PY; Saugy M
    Bioanalysis; 2012 Jul; 4(13):1633-43. PubMed ID: 22831479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments.
    Ashenden M; Sharpe K; Habel J; Vicentin A; Schischka S
    J Clin Pathol; 2013 Mar; 66(3):232-7. PubMed ID: 23112117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preanalytical variability: the dark side of the moon in blood doping screening.
    Lippi G; Banfi G; Maffulli N
    Eur J Appl Physiol; 2010 Jul; 109(5):1003-5. PubMed ID: 20333397
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing.
    Thevis M; Loo JA; Loo RR; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(3):297-304. PubMed ID: 17200979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
    Smith R; Barnsley L; Kannangara S; Mace A
    Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.
    Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Gargiullo E; Parisi A; Pigozzi F
    Blood Cells Mol Dis; 2001; 27(3):559-71. PubMed ID: 11355895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
    Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
    Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the legal framework applicable to the marker method for the detection of human growth hormone.
    Young RR; Bielak JS; Horvitz SL
    Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preanalytical phase of soluble receptor of transferrin.
    Banfi G
    Int J Sports Med; 2007 Jan; 28(1):88-9. PubMed ID: 17203438
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
    Lippi G; Franchini M; Guidi G
    Haematologica; 2004 Apr; 89(4):ELT05. PubMed ID: 15075118
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.